Citation: Ma. Young et al., ESTABLISHING THE DOSE-RESPONSE CURVE FOR METABOLIC CONTROL WITH TROGLITAZONE, AN INSULIN ACTION ENHANCER, IN TYPE-2 DIABETES PATIENTS, Annals of medicine, 30(2), 1998, pp. 206-212
Authors:
KUMAR S
PRANGE A
SCHULZE J
LETTIS S
BARNETT AH
Citation: S. Kumar et al., TROGLITAZONE, AN INSULIN ACTION ENHANCER, IMPROVES GLYCEMIC CONTROL AND INSULIN SENSITIVITY IN ELDERLY TYPE-2 DIABETIC-PATIENTS, Diabetic medicine, 15(9), 1998, pp. 772-779
Citation: Ma. Young et al., IMPROVEMENT IN THE GASTROINTESTINAL ABSORPTION OF TROGLITAZONE WHEN TAKEN WITH, OR SHORTLY AFTER, FOOD, British journal of clinical pharmacology, 45(1), 1998, pp. 31-35
Citation: Ma. Young et al., CONCOMITANT ADMINISTRATION OF CHOLESTYRAMINE INFLUENCES THE ABSORPTION OF TROGLITAZONE, British journal of clinical pharmacology, 45(1), 1998, pp. 37-40
Citation: Ma. Young et al., COADMINISTRATION OF ACETAMINOPHEN AND TROGLITAZONE - PHARMACOKINETICSAND SAFETY, Journal of clinical pharmacology, 38(9), 1998, pp. 819-824
Authors:
HOVORKA R
ECKLAND DJA
HALLIDAY D
LETTIS S
ROBINSON CE
BANNISTER P
YOUNG MA
BYE A
Citation: R. Hovorka et al., CONSTANT INFUSION AND BOLUS INJECTION OF STABLE-LABEL TRACER GIVE REPRODUCIBLE AND COMPARABLE FASTING HGO, American journal of physiology: endocrinology and metabolism, 36(1), 1997, pp. 192-201
Citation: Ea. Foot et al., EVIDENCE FOR TROGLITAZONE, A NOVEL ANTIDIABETIC AGENT, ACTING AS AN INSULIN ACTION ENHANCER, Diabetologia, 40, 1997, pp. 1209-1209
Citation: Ma. Young et al., TROGLITAZONE ADDED TO A SULFONYLUREA SHOWS A DOSE-RESPONSE CONSISTENTWITH MONOTHERAPY, Diabetologia, 40, 1997, pp. 1370-1370
Authors:
LEUTENEGGER M
SACCA L
ALDERTON C
ECKLAND D
LETTIS S
Citation: M. Leutenegger et al., DOUBLE-MASKED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY OF TROGLITAZONE10 TO 200 MG ONCE-DAILY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Current therapeutic research, 58(7), 1997, pp. 403-416
Authors:
KUMAR S
BOULTON AJM
BECKNIELSEN H
BERTHEZENE F
MUGGEO M
PERSSON B
SPINAS GA
DONOGHUE S
LETTIS S
STEWARTLONG P
Citation: S. Kumar et al., TROGLITAZONE, AN INSULIN ACTION ENHANCER, IMPROVES METABOLIC CONTROL IN NIDDM PATIENTS (VOL 39, PG 701, 1996), Diabetologia, 39(10), 1996, pp. 1245-1245
Authors:
ENTWISLE SJ
FOWLER PA
THOMAS M
ECKLAND DJA
LETTIS S
YORK M
FREEDMAN PS
Citation: Sj. Entwisle et al., THE EFFECTS OF ORAL SUMATRIPTAN, A 5-HT1 RECEPTOR AGONIST, ON CIRCULATING ACTH AND CORTISOL CONCENTRATIONS IN MAN, British journal of clinical pharmacology, 39(4), 1995, pp. 389-395
Authors:
HUDSON N
MURRAY FE
COLE AT
TURNBULL GM
LETTIS S
HAWKEY CJ
Citation: N. Hudson et al., RANITIDINE BISMUTH CITRATE AND ASPIRIN-INDUCED GASTRIC-MUCOSAL INJURY, Alimentary pharmacology & therapeutics, 7(5), 1993, pp. 515-521
Authors:
WILDERSMITH CH
SMITH JTL
BETTSCHEN HU
LETTIS S
MERKI HS
Citation: Ch. Wildersmith et al., CYTOPROTECTIVE EFFECT OF RANITIDINE BISMUTH CITRATE AGAINST ASPIRIN-INDUCED UPPER GI TRACT MUCOSAL DAMAGE, Gastroenterology, 104(4), 1993, pp. 224-224